Financials
- Market Capitalization 4.1 B
- Employee 838
- Founded 2014
- CEO Mark Crossley
- Website www.indivior.com
- Headquarter Delaware, United States
- FIGI BBG01ZTXFLQ6
- Industry 药品制造—专业与仿制药
总收入
净利润
每股基本收益(基本 EPS)
总债务
自由现金流
现金及现金等价物
市盈率
14.71
市销率
3.93
Related tickers
| # | 姓名 | 价格 | 24小时 % | 7天 % | 一个月 % | 一年 % | 市值 | 最近7天 | |
|---|---|---|---|---|---|---|---|---|---|
| 1149 | LNTH Lantheus Holdings, Inc. - Common Stock | 100.97 USD | +0.20% | +0.47% | -1.74% | +80.11% | 6.59 B USD | ||
| 1274 | AMRX Amneal Pharmaceuticals, Inc. - Class A Common Stock | 17.44 USD | -0.57% | -2.41% | -5.42% | +65.31% | 5.57 B USD | ||
| 1783 | RGC Regencell Bioscience Holdings Limited - Ordinary Shares | 5.54 USD | +0.73% | +4.14% | -8.58% | -60.17% | 2.74 B USD | ||
| 1837 | SUPN Supernus Pharmaceuticals, Inc. - Common Stock | 43.82 USD | +0.21% | -3.07% | -13.14% | -18.85% | 2.55 B USD |